Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RAMEZANI TAYEBEH; Nabiuni Mohamad; BAHARARA JAVAD; PARIVAR KAZEM; NAMVAR FARIDEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pharmaceutical Research Year:2019 | Volume:18 | Issue:1 Page(s): 222-231

Download Full-Text

View:

172

Download:

112

Cites:

Information Journal Paper

Title

Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation

Author(s)

Keywords

Cisplatin

Silver

Nanoparticles

Curcumin

Resistance

Abstract

Today, drug Resistance is one of the major problems in fight against cancer. Therefore, combination of therapeutic strategies was raised to effectively improve disease prognosis. In this regard, Silver Nanoparticles (AgNPs) are considered significant due to their anticancer properties. This study aimed to return sensitivity to Cisplatin to A2780 Cisplatin-Resistance cell lines in the presence of biogenic synthesis Curcumin-coated Silver Nanoparticles (cAgNPs). Synergic cellular effects of cAgNPs and Cisplatin on ovarian carcinoma 2780 resistant to Cisplatin cells were assessed using MTT assay, Acridine orange (AO)/propidium iodide (PI), DAPI staining, Annexin V/PI assay, and caspase 3/9 activation assay. Finally, expression of p53 and MMP-9 genes were evaluated using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). According to the results, 8 μ g/mL and 62 μ g/mL of cAgNPs and Cisplatin led to 50% cell death in 48 h, respectively. Therefore, we combined non-toxic concentration of Nanoparticles (1-5 μ g/mL) with Cisplatin (2. 5 μ g/mL). Decreased proliferation rate was about 50% for synergic use of Cisplatin (2. 5 μ g/mL) and cAgNPs (2 μ g/ mL). According to the results, cell death induction significantly increased by AO/PI, DAPI staining and Annexin V/PI assay in the combined group. Moreover, activity of caspase 3/9 significantly increased in the mentioned group. The combined use of cAgNPs and Cisplatin resulted in upregulated expression of p53 gene and downregulated expression of MPP-9 gene. As observed in this study, a combination of cAgNPs and Cisplatin increased the efficiency of apoptosis induction in A2780 cells, compared to the independent use of Cisplatin or cAgNPs.

Cites

No record.

References

No record.

Cite

APA: Copy

RAMEZANI, TAYEBEH, Nabiuni, Mohamad, BAHARARA, JAVAD, PARIVAR, KAZEM, & NAMVAR, FARIDEH. (2019). Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 18(1), 222-231. SID. https://sid.ir/paper/289223/en

Vancouver: Copy

RAMEZANI TAYEBEH, Nabiuni Mohamad, BAHARARA JAVAD, PARIVAR KAZEM, NAMVAR FARIDEH. Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2019;18(1):222-231. Available from: https://sid.ir/paper/289223/en

IEEE: Copy

TAYEBEH RAMEZANI, Mohamad Nabiuni, JAVAD BAHARARA, KAZEM PARIVAR, and FARIDEH NAMVAR, “Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 18, no. 1, pp. 222–231, 2019, [Online]. Available: https://sid.ir/paper/289223/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops